Cellular immunotherapies for leukemias and lymphomas, particularly new CAR-T cell approaches for acute myeloid leukemia, and the side effects of these therapies.

Gene therapies for inherited and acquired retinal diseases based on new viral vectors.

Development of new cell therapies for cancer and infections.

Extraction and GMP-compliant manufacturing of cell therapies.